海外の治験の状況「1」での検索結果
1495件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Dapagliflozin in Type 1 Diabetes
- Fasting Glucose;Glucose Excursion;Glycemic Control
- Austria
- 2014-08-06
Authorised
- Multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose finding study to evaluate the efficacy, safety, and tolerability of three doses of ACT-128800, an oral S1P1 receptor agonist, administered for twenty-four weeks in patients with relapsing-remitting multiple sclerosis
- relapsing-remitting multiple sclerosis MedDRA version: 9.1 Level: LLT Classification code 10063399 Term: Relapsing-remitting multiple sclerosis
- Austria, Bulgaria, Czech Republic, Finland, France, Hungary, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom
- 2009-03-26
Not recruiting
- Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
- Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
- Austria, Belarus, Canada, Czech Republic, Finland, Germany, Hungary, Israel, Italy, Lithuania, Poland, Russian Federation, Spain, United States
- 2010-04-13
Not recruiting
- Phase 1 Dosing Study of BAX 513 in Healthy Volunteers
- Healthy Volunteers
- Austria
- 2010-02-04
Not Recruiting
- A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety and tolerability of two doses of ACT-128800, an oral S1P1 receptor agonist, administered up to twenty-eight weeks in patients with moderate to severe chronic plaque psoriasis
- Moderate to severe chronic plaque psoriasis MedDRA version: 12.1 Level: LLT Classification code 10037153 Term: Psoriasis
- Austria, Bulgaria, Czech Republic, Denmark, Estonia, Hungary, Italy, Latvia, Lithuania, Slovakia, Spain, Sweden, United Kingdom
- 2010-06-08
Authorised
- A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
- Lymphoid or myeloid neoplasm with 8p11 rearrangement known to lead to FGFR1 activation;Therapeutic area: Diseases [C] - Cancer [C04]
- Austria, France, Germany, Italy, Spain, Switzerland, United Kingdom, United States
- 2017-01-24
Not recruiting
- Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder
- Bipolar Disorder;Bipolar Disorder;Bipolar Disorder;Bipolar Disorder
- Austria, Canada, Colombia, Czech Republic, Germany, Guatemala, Peru, Russian Federation, Slovakia, South Africa, Ukraine, United States, Venezuela
- 2005-08-29
Not recruiting
- AMS INSIGHT 1 Study - Bioabsorbable Metal Stent Investigation in Chronic Limb Ischemia Treatment
- Peripheral Artery Disease
- Austria, Belgium, Germany, Netherlands
- 2007-12-12
Not Recruiting
- Multicenter, randomized, double-blind, placebo-controlled, Phase IIa study to evaluate the efficacy, safety, and tolerability of ACT-128800, an S1P1 receptor agonist, administered for 6 weeks to subjects with moderate to severe chronic plaque psoriasis
- Moderate to severe chronic plaque psoriasis MedDRA version: 9.1 Level: LLT Classification code 10037153 Term: Psoriasis
- Austria, France, Germany, Hungary
- 2008-07-04
Not recruiting
- A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes
- Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1
- Austria
- 2010-08-02